Human biodistribution and dosimetry of the PET radioligand [ 11C]flumazenil (FMZ)

Molecular Imaging and Biology

Volumn 14, Issue 1, 2012, Pages 115-122

  Laymon, Charles M ^a   Narendran, Rajesh ^a   Mason, Neale S ^a   Carney, Jonathan P ^a   Lopresti, Brian J ^a   Mathis, Chester A ^a   Mountz, James M ^a   Sashin, Donald ^a   Frankle, W Gordan ^b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

11C flumazenil; Biodistributiom; Dosimetry; Positron emission tomography

Indexed keywords

FLUMAZENIL C 11;

ADULT; ARTICLE; BLADDER WALL; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR IMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOACTIVITY; RADIOASSAY; SEX DIFFERENCE; WHOLE BODY IMAGING; WHOLE BODY RADIATION;

ADULT; CARBON RADIOISOTOPES; FEMALE; FLUMAZENIL; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84861481536     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0478-2     Document Type: Article

References (53)

1. Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: The secondgeneration personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46:1023-1027 (Pubitemid 43733519)
2. Persson A, Ehrin E, Eriksson L, Farde L, Hedstrom CG, Litton JE et al (1985) Imaging of [11 C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 19:609-622 (Pubitemid 16198896)
3. Pappata S, Samson Y, Chavoix C, Prenant C, Maziere M, Baron JC (1988) Regional specific binding of [11 C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 8:304-313
4. Shinotoh H, Iyo M, Yamada T, Inoue O, Suzuki K, Itoh T et al (1989) Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography. Psychopharmacology (Berlin) 99:202-207 (Pubitemid 19215218)
5. Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE (1991) Compartmental analysis of [11 C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11:735-744
6. Abadie P, Baron JC, Bisserbe JC, Boulenger JP, Rioux P, Travere JM et al (1992) Central Benzodiazepine Receptors in Human Brain - Estimation of Regional B(Max) and K(D) Values with Positron Emission Tomography. Eur J Pharmacol 213:107-115
7. Price JC, Mayberg HS, Dannals RF, Wilson AA, Ravert HT, Sadzot B et al (1993) Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11 C]flumazenil. J Cereb Blood Flow Metab 13:656-667 (Pubitemid 23187509)
8. Delforge J, Pappata S, Millet P, Samson Y, Bendriem B, Jobert A et al (1995) Quantification of benzodiazepine receptors in human brain using pet, [C-11] Flumazenil, and a single-experiment protocol. J Cereb Blood Flow Metab 15:284-300
9. Lassen NA, Bartenstein PA, Lammertsma AA, Prevett MC, Turton DR, Luthra SK et al (1995) Benzodiazepine receptor quantification in-vivo in humans using [C-11] flumazenil and pet - application of the steadystate principle. J Cereb Blood Flow Metab 15:152-165
10. Salmi E,Aalto S,Hirvonen J, Langsjo JW, MaksimowAT,Oikonen Vet al (2008) Measurement of GABA(A) receptor binding in vivo with [C-11] flumazenil: Atest-retest study in healthy subjects.Neuroimage 41:260-269
11. Frankle WG, Cho RY, Narendran R, Mason NS, Vora S, Litschge M et al (2009) Tiagabine Increases [C-11] flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology 34:624-633
12. Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN et al (2009) [F-18]Flumazenil binding to central benzodiazepine receptor studies by PET - Quantitative analysis and comparisons with [C-11]flumazenil. Neuroimage 45:891-902
13. Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L (1988) Invivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2:863-866
14. Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA et al (1993) In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 43:1998-2006 (Pubitemid 23318867)
15. Prevett MC, Lammertsma AA, Brooks DJ, Bartenstein PA, Patsalos PN, Fish DR et al (1995) Benzodiazepine-Gaba(a) receptors in idiopathic generalized epilepsy measured with [C-11] flumazenil and positron emission tomography. Epilepsia 36:113-121
16. Savic I, Thorell JO, Roland P (1995) [C-11] Flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 36:1225-1232 (Pubitemid 3007771)
17. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS (1996) Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An C-11-flumazenil PET study. Ann Neurol 40:188-198
18. Szelies B, Weber-Luxenburger G, Pawlik G, Kessler J, Holthoff V, Mielke R et al (1996) MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 3:109-118 (Pubitemid 26141321)
19. Koepp MJ, Richardson MP, Brooks DJ, Cunningham VJ, Duncan JS (1997) Central benzodiazepine/gamma-aminobutyric acid(A) receptors in idiopathic generalized epilepsy: An [C-11]flumazenil positron emission tomography study. Epilepsia 38:1089-1097 (Pubitemid 27424152)
20. Juhasz C, Asano E, Shah A, Chugani DC, Batista CEA, Muzik O et al (2009) Focal decreases of cortical GABA(A) receptor binding remote from the primary seizure focus: What do they indicate ? Epilepsia 50:240-250
21. Juhasz C, Nagy F, Watson C, da Silva EA, Muzik O, Chugani DC et al (1999) Glucose and [C-11]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology 53:2037-2045
22. Szelies B, Sobesky J, Pawlik G, Mielke R, Bauer B, Herholz K et al (2002) Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [C-11]-flumazenil PET. Eur J Neurol 9:137-142 (Pubitemid 35013928)
23. Padma MV, Simkins R, White P, Satter M, Christian BT, Dunigan K et al (2004) Clinical utility of 11 C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Neurol India 52:457-462 (Pubitemid 40110563)
24. Bouvard S, Costes N, Bonnefoi F, Lavenne F, Mauguiere F, Delforge J et al (2005) Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [C-11]flumazenil-PET study. Brain 128:1330-1343 (Pubitemid 40826187)
25. Heiss WD, Kracht L, Grond M, Rudolf J, Bauer B, Wienhard K et al (2000) Early [C-11]flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 31:366-369 (Pubitemid 30078167)
26. Heiss WD, Sobesky J, Smekal U, Kracht LW, Lehnhardt FG, Thiel A et al (2004) Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke. Stroke 35:1892-1898 (Pubitemid 38971871)
27. Guadagno JV, Jones PS, Aigbirhio FI, Wang D, Fryer TD, Day DJ et al (2008) Selective neuronal loss in rescued penumbra relates to initial hypoperfusion. Brain 131:2666-2678
28. Suzuki Y, Horie C, Kiyosawa M, Nariai T, Mochizuki M, Oda K et al (2008) Measurement of the C-11-flumazenil binding in the visual cortex predicts the prognosis of hemianopia. J Neurol Sci 268:102-107
29. Chavoix C, Samson Y, Pappata S, Prenant C, Maziere M, Seck A et al (1990) Positron emission tomography study of brain benzodiazepine receptors in Friedreich's ataxia. Can J Neurol Sci 17:404-409
30. Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE et al (1993) Positron Emission Tomography Measures of Benzodiazepine Receptors in Huntingtons-Disease. Ann Neurol 34:76-81 (Pubitemid 23188730)
31. Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St Laurent RT (1995) Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Ann Neurol 38:176-185
32. Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE (1995) Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch Neurol 52:314-317
33. Klumpers UMH, Veltman DJ, Drent ML, Boellaard R, Comans EFI, Meynen G et al (2010) Reduced parahippocampal and lateral temporal GABA(A)-[C-11]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging 37:565-574
34. Ihara M, Tomimoto H, Ishizu K, Yoshida H, Sawamoto N, Hashikawa K et al (2007) Association of vascular parkinsonism with impaired neuronal integrity in the striatum. J Neural Transm 114:577-584 (Pubitemid 46664050)
35. Geuze E, van Berckel BNM, Lammertsma AA, Boellaard R, de Kloet CS, Vermetten E et al (2008) Reduced GABA(A) benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 13:74-83 (Pubitemid 350275183)
36. Pearl PL, Gibson KM, Quezado Z, Dustin I, Taylor J, Trzcinski S et al (2009) Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 73:423-429
37. Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C et al (1993) Pet analysis of [C-11] flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Research Neuroimaging 50:1-13 (Pubitemid 23135267)
38. Lingford-Hughes AR, Wilson SJ, Cunningham VJ, Feeney A, Stevenson B, Brooks DJ et al (2005) GABA-benzodiazepine receptor function in alcohol dependence: a combined C-11-flumazenil PET and pharmacodynamic study. Psychopharmacology 180:595-606 (Pubitemid 41317856)
39. Yamauchi H, Kudoh T, Kishibe Y, Iwasaki J, Kagawa S (2005) Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: A C-11-flumazenil PET study. J Nucl Med 46:1973-1979 (Pubitemid 46657442)
40. Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ et al (2005) Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [C-11]flumazenil PET. Brain 128:1323-1329 (Pubitemid 40826186)
41. Wicks P, Turner MR, Abrahams S, Hammers A, Brooks DJ, Leigh PN et al (2008) Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (C-11)-flumazenil PET study. Amyotroph Lateral Scler 9:43-49 (Pubitemid 351260372)
42. Capaday C, Richardson MP, Rothwell JC, Brooks DJ (2000) Long-term changes of GABAergic function in the sensorimotor cortex of amputees - A combined magnetic stimulation and C-11-flumazenil PET study. Exp Brain Res 133:552-556 (Pubitemid 30609381)
43. Salmi E, Kaisti KK, Metsahonkala L, Oikonen V, Aalto S, Nagren K et al (2004) Sevoflurane and propofol increase C-11-flumazenil binding to gamma-aminobutyric Acid(A) receptors in humans. Anesth Analg 99:1420-1426 (Pubitemid 39407291)
44. Halldin C, Stone-Elander S, Thorell J-O, Persson A, Sedvall G (1988) 11 C-labelling of Ro 15-1788 in two different positions, and also 11 Clabelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. Int J Radiat Appl Instrum A Appl Radiat Isot 39:993-997
45. Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang YY, Hackett E et al (2006) Biodistribution and radiation dosimetry of the dopamine D- 2 ligand C-11-raclopride determined from human whole-body PET. J Nucl Med 47:313-319 (Pubitemid 46780897)
46. Stabin MG, Siegel JA (2003) Physical models and dose factors for use in internal dose assessment. Health Phys 85:294-310 (Pubitemid 36999340)
47. ICRP (2007) P103: The 2007 Recommendations of the International Commission on Radiological Protection. Ann ICRP 37:1-332
48. Nugent AC, Neumeister A, Devets WC, Eckelman WC, Channing P, Herscovitch P (2004) Human biodistribution and dosimetry of the PET benzodiazepine receptor radioligand [11 C]Flumazenil. J Nucl Med 45 (Supplement):434P
49. Laymon CM, Narendran R, Mason NS, Carney JP, Lopresti BJ, Mountz JM et al (2009) Human dosimetry of the PET radioligand [C-11] Flumazenil (FMZ). J Nucl Med 50(Supplement):387P
50. Stabin MG (1996) MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 37:538-546
51. Laymon CM, Mason NS, Frankle WG, Carney JP, Lopresti BJ, Litschge MY et al (2009) Human biodistribution and dosimetry of the D2/3 agonist 11 C-N-propylnorapomorphine (11 C-NPA) determined from PET. J Nucl Med 50:814-817. doi:10.2967/jnumed.108.058131
52. Wrixon AD (2008) New ICRP recommendations. J Radiol Prot 28:161-168. doi:10.1088/0952-4746/28/2/r02
53. Verbruggen A, Coenen HH, Deverre JR, Guilloteau D, Langstrom B, Salvadori PA et al (2008) Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU. Eur J Nucl Med Mol Imaging 35:2144-2151. doi:10.1007/s00259-008-0853-7